Titan Pharmaceuticals Inc De

CUSIP 888314705COM NEWTTNPUSDQ4 2025

Titan Pharmaceuticals Inc De — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

14.1%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest Aug 21, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Aug 21, 2024	Sire Group Ltd.	13D/A	14.1%	150.1K	SEC
2	Apr 5, 2024	Sire Group Ltd.	13D/A	14.1%	150.1K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Corecap Advisors, LLC	88	$147
2	Global Wealth Strategies & Associates	2	$3
3	Caldwell Sutter Capital, Inc.	1	$2
4	St Germain D J Co Inc	1	$2